IPA – immunoprecise antibodies ltd. (US:NASDAQ)
Stock Stats
News
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its price target lowered by analysts at HC Wainwright from $7.00 to $5.00. They now have a "buy" rating on the stock.
ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) [Yahoo! Finance]
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Form 6-K ImmunoPrecise Antibodies For: Mar 28
Form 6-K ImmunoPrecise Antibodies For: Jan 31
Form 6-K ImmunoPrecise Antibodies For: Mar 13
Form 6-K ImmunoPrecise Antibodies For: Mar 12
Form 6-K ImmunoPrecise Antibodies For: Feb 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.